Opis projektu
Spersonalizowane rozwiązanie do monitorowania poziomu witaminy B6 w organizmie
Witamina B6 odgrywa w organizmie człowieka kluczową rolę. Jej niedobór może powodować poważne problemy zdrowotne. Niedobór witaminy B6 u osób w podeszłym wieku, alkoholików i diabetyków wiąże się z chorobami układu krążenia, rakiem i udarem. Istniejące systemy monitorowania poziomu witaminy B6 w organizmie nie są ani szybkie, ani wiarygodne. Ponadto wymagają one zaangażowania lekarza, jak również laboratorium, co zwiększa koszty i czas diagnostyki. W ramach finansowanego ze środków UE projektu B6VitaStat proponowane jest łatwe w użyciu urządzenie wykorzystujące tanią i niezawodną technikę do stałego monitorowania poziomu witaminy B6 u pacjentów objętych kategorią ryzyka. Innowacyjne urządzenie oferuje zindywidualizowaną diagnozę poziomów witaminy B6 i może być stosowane w każdym środowisku, również w krajach słabiej rozwiniętych.
Cel
Vitamin B6 is an essential nutrient and part of a well-balanced diet. However, B6 deficiency is often observed in elderly people, diabetes patients and alcoholics and associated with higher rates of cardiovascular disease, stroke and cancer. All these risk populations need a stringent and continuous monitoring of B6 levels. At present B6 detection systems suffer from limited speed, scope, convenience and reliability. These tests require a medical doctor as well as external laboratories with expensive and specialized equipment for analysis increasing the overall costs. We here develop a customized assay for vitamin B6 detection with a desired application as reliable, cheap and easy-to-use point-of-care device. This assay system, termed B6VitaStat, is based on the direct monitoring of cofactor binding into diverse enzyme active sites which will be performed in erythrocytes drawn from blood. Key to B6VitaStat is a tailored probe which mimics the structure of the cofactor. This probe is equipped with a recognition tag allowing to visualize binding to B6-dependent enzymes. The less B6 is bound, the stronger the signal, the higher the overall deficiency. This principle will be incorporated in an easy-to-use device that is based on an antibody printed microarray hallmarked by its cheap and reproducible production. The robust array can be used world-wide including developing countries with less pronounced medical infrastructure. The B6VitaStat team combines complementary expertise including chemistry, engineering and entrepreneurship, which will provide a basis for the envisioned commercialization. Given that B6VitaStat will be the first device of this class we estimate a significant cost reduction compared to current clinical procedures. Overall, we aim to introduce a new device for constant monitoring B6 vitamin status in risk patients and provide a cheap, easy-to-use and reliable method suited for all kinds of applications including those in less-developed countries.
Dziedzina nauki
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health scienceshealth sciencesnutrition
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
- medical and health sciencesbasic medicineneurologystroke
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsenzymes
Program(-y)
System finansowania
ERC-POC-LS - ERC Proof of Concept Lump Sum PilotInstytucja przyjmująca
80333 Muenchen
Niemcy